We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.49B
AUM Growth
-$91.2M
Cap. Flow
-$150M
Cap. Flow %
-2.31%
Top 10 Hldgs %
18.45%
Holding
1,603
New
478
Increased
239
Reduced
260
Closed
489

Sector Composition

Rank Sector Weight
1 Communication Services 3.18%
2 Healthcare 3.02%
3 Financials 2.03%
4 Technology 1.9%
5 Consumer Discretionary 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHN icon
701
First Horizon
FHN
$12.2B
$883K 0.01%
56,000
BIIB icon
702
Biogen
BIIB
$29.9B
$876K 0.01%
+3,780
New +$821K
UAL icon
703
United Airlines
UAL
$41.4B
$876K 0.01%
+18,000
New +$906K
NU icon
704
CALL
Nu Holdings
NU
$69.4B
$864K 0.01%
67,000
-133,000
-67% -$1.55M
LOGC
705
CALL
DELISTED
ContextLogic
LOGC
$857K 0.01%
+150,000
New +$825K
HELE icon
706
CALL
Helen of Troy
HELE
$685M
$853K 0.01%
9,200
IOT icon
707
PUT
Samsara
IOT
$21.9B
$843K 0.01%
+25,000
New +$862K
HCP
708
CALL
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$842K 0.01%
+25,000
New +$777K
HOG icon
709
PUT
Harley-Davidson
HOG
$2.65B
$839K 0.01%
25,000
-75,800
-75% -$2.75M
SGRY icon
710
Surgery Partners
SGRY
$2.09B
$835K 0.01%
+35,100
New +$901K
ESPR
711
CALL
DELISTED
Esperion Therapeutics
ESPR
$819K 0.01%
368,800
+143,800
+64% +$338K
NTLA icon
712
PUT
Intellia Therapeutics
NTLA
$1.49B
$810K 0.01%
36,200
BMEA icon
713
CALL
Biomea Fusion
BMEA
$86.8M
$810K 0.01%
180,000
-90,000
-33% -$915K
NVS icon
714
Novartis
NVS
$292B
$798K 0.01%
+7,500
New +$753K
INTC icon
715
Intel
INTC
$456B
$793K 0.01%
+25,600
New +$839K
ACI icon
716
PUT
Albertsons Companies
ACI
$5.65B
$790K 0.01%
40,000
+15,000
+60% +$306K
CC icon
717
CALL
Chemours
CC
$2.54B
$790K 0.01%
+35,000
New +$917K
INDV icon
718
Indivior Pharmaceuticals
INDV
$4.57B
$790K 0.01%
+49,000
New +$884K
MODV
719
DELISTED
ModivCare
MODV
$787K 0.01%
30,000
+18,400
+159% +$466K
FYBR
720
CALL
DELISTED
Frontier Communications
FYBR
$785K 0.01%
+30,000
New +$747K
SHLS icon
721
Shoals Technologies Group
SHLS
$1.54B
$784K 0.01%
+125,700
New +$1M
FDS icon
722
Factset
FDS
$9.55B
$776K 0.01%
+1,900
New +$807K
GSK icon
723
PUT
GSK
GSK
$103B
$770K 0.01%
+20,000
New +$841K
GERN icon
724
Geron
GERN
$821M
$763K 0.01%
+180,000
New +$702K
SYM icon
725
Symbotic
SYM
$5.79B
$759K 0.01%
+21,600
New +$874K

Similar funds

Caption Management's Q2 2024 Portfolio in Review

As of Q2 2024, Caption Management held 1,603 positions worth $6.49B, down 1.4% from $6.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management's Q2 2024 filing shows 478 new, 239 increased, 260 reduced and 489 closed positions. Its largest new stake was Alphabet (Google) Class C: 233,700 shares worth $42.9M. The largest sale was Meta Platforms (Facebook), an estimated $25.5M.

By sector, the portfolio is most concentrated in Communication Services at 3.2% of assets, up from 2.6% a quarter earlier, followed by Healthcare and Financials.

  • Caption Management's largest Q2 2024 buy was Alphabet (Google) Class C: 233,700 shares worth $42.9M.
  • Caption Management added most to First Solar in Q2 2024, an estimated $18.5M increase.
  • Caption Management's biggest Q2 2024 reduction was Intra-Cellular Therapies Inc., cutting an estimated $18.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2024.
  • Caption Management opened 478 new positions and closed 489 in Q2 2024.
  • Caption Management's portfolio value fell 1.4% quarter-over-quarter to $6.49B.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.